1. Home
  2. LSE vs LUNG Comparison

LSE vs LUNG Comparison

Compare LSE & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leishen Energy Holding Co. Ltd. Ordinary Shares

LSE

Leishen Energy Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$5.56

Market Cap

88.5M

Sector

Industrials

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.53

Market Cap

97.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSE
LUNG
Founded
2007
1995
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.5M
97.1M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
LSE
LUNG
Price
$5.56
$2.53
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
4.8K
887.5K
Earning Date
01-30-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.64
EPS
N/A
N/A
Revenue
N/A
$90,497,000.00
Revenue This Year
N/A
$2.48
Revenue Next Year
N/A
$18.46
P/E Ratio
$61.76
N/A
Revenue Growth
N/A
8.01
52 Week Low
$3.20
$1.13
52 Week High
$6.98
$2.89

Technical Indicators

Market Signals
Indicator
LSE
LUNG
Relative Strength Index (RSI) 61.90 70.25
Support Level $4.56 $1.27
Resistance Level $5.53 $2.66
Average True Range (ATR) 0.35 0.18
MACD 0.07 0.01
Stochastic Oscillator 77.03 85.34

Price Performance

Historical Comparison
LSE
LUNG

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: